Okey Stephanie's Form 4 filing
Crinetics Pharmaceuticals, Inc. (CRNX) · filed Sep 1, 2026
- Accession no.
- 0001628280-26-059905
- Filed
- Sep 1, 2026, 5:01 PM ET
- Trade date
- Sep 1, 2026
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 7 derivative transactions. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Okey StephanieCIK 0001742616 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | Common Stock | DReturned to the companyDisposed | −6,400 | $85.00 | −$544,000 | 5,925 | Direct | |
| Sep 1, 2026 | Common Stock | DReturned to the companyDisposed | −5,925 | $85.00 | −$503,625 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | Common Stock | DReturned to the companyDisposed | −25,000 | $60.85 | −$1,521,250 | 0 | Direct | |
| Sep 1, 2026 | Common Stock | DReturned to the companyDisposed | −12,500 | $61.77 | −$772,125 | 0 | Direct | |
| Sep 1, 2026 | Common Stock | DReturned to the companyDisposed | −17,500 | $64.77 | −$1,133,475 | 0 | Direct | |
| Sep 1, 2026 | Common Stock | DReturned to the companyDisposed | −17,500 | $64.68 | −$1,131,900 | 0 | Direct | |
| Sep 1, 2026 | Common Stock | DReturned to the companyDisposed | −12,500 | $40.29 | −$503,625 | 0 | Direct | |
| Sep 1, 2026 | Common Stock | DReturned to the companyDisposed | −10,350 | $52.67 | −$545,134.5 | 0 | Direct | |
| Sep 1, 2026 | Common Stock | DReturned to the companyDisposed | −9,730 | $49.13 | −$478,034.9 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.